Alphatec Holdings (ATEC) Cash & Current Investments (2010 - 2026)
Alphatec Holdings (ATEC) reported Cash & Current Investments of $139.9 million for Q1 2026, down 8.7% on a YoY basis from $153.2 million in Q1 2025, and down 12.99% sequentially from $160.8 million in Q4 2025.
Alphatec Holdings (ATEC) Cash & Current Investments (2010 - 2026) Analysis & Trends
Alphatec Holdings (ATEC) has 17 years of Cash & Current Investments data on file, last reported at $139.9 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments fell 8.7% year-over-year to $139.9 million; the trailing twelve-month figure through Mar 2026 stood at $139.9 million (down 8.7% YoY), and the FY2025 full-year result was $160.8 million, up 15.82% from the prior year.
- Cash & Current Investments declined to $139.9 million in Q1 2026, from $160.8 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $221.0 million in Q4 2023 to a low of $81.0 million in Q3 2024.
- A 5-year average of $131.9 million and a median of $138.8 million in 2024 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments slumped 54.77% in 2022 and soared 160.9% in 2023, its largest moves.
- Tracing ATEC's Cash & Current Investments over 5 years: stood at $84.7 million in 2022, then jumped by 160.9% to $221.0 million in 2023, then tumbled by 37.17% to $138.8 million in 2024, then advanced by 15.82% to $160.8 million in 2025, then fell by 12.99% to $139.9 million in 2026.
- Business Quant data shows ATEC's Cash & Current Investments at $139.9 million in Q1 2026, $160.8 million in Q4 2025, and $155.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 3.67 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | 2.29 Bn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 1.12 Bn |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Alphatec Holdings | 1.35 Bn | 1.21 Bn | 136.48 Mn | 139.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139.91 Mn |
| Dec 31, 2025 | 160.81 Mn |
| Sep 30, 2025 | 155.74 Mn |
| Jun 30, 2025 | 157.06 Mn |
| Mar 31, 2025 | 153.24 Mn |
| Dec 31, 2024 | 138.84 Mn |
| Sep 30, 2024 | 80.98 Mn |
| Jun 30, 2024 | 99.83 Mn |
| Mar 31, 2024 | 144.09 Mn |
| Dec 31, 2023 | 220.97 Mn |
| Sep 30, 2023 | 122.53 Mn |
| Jun 30, 2023 | 101.02 Mn |
| Mar 31, 2023 | 116.70 Mn |
| Dec 31, 2022 | 84.70 Mn |
| Sep 30, 2022 | 106.11 Mn |
| Jun 30, 2022 | 107.47 Mn |
| Mar 31, 2022 | 151.81 Mn |
| Dec 31, 2021 | 187.25 Mn |
| Sep 30, 2021 | 223.87 Mn |
| Jun 30, 2021 | 76.58 Mn |